1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow HIGM-1: new trials by email Literature Review of HIGM-1 trials Research Report on HIGM-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) Hematopoietic Stem Cell Transplant - Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | Phase 2 | Completed | Medical College of Wisconsin | 47 | 2013-12-01 | 2022-12-08 |
Granulomatous Disease, Chronic (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Leukocyte adhesion deficiency type 1 (1) · Lymphohistiocytosis, Hemophagocytic (1)
Blood Protein Disorders (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Dysgammaglobulinemia (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Histiocytosis, Non-Langerhans-Cell (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Leukocyte Disorders (1) · Lymphatic Diseases (1)
Medical College of Wisconsin (1)
Canada (1) · United States (1)
U10HL069294 (1), U24CA076518 (1)